Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Janux Therapeutics (JANX) Research & Development: 2020-2024

Historic Research & Development for Janux Therapeutics (JANX) over the last 5 years, with Dec 2024 value amounting to $68.4 million.

  • Janux Therapeutics' Research & Development rose 86.04% to $34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.2 million, marking a year-over-year increase of 92.49%. This contributed to the annual value of $68.4 million for FY2024, which is 24.52% up from last year.
  • As of FY2024, Janux Therapeutics' Research & Development stood at $68.4 million, which was up 24.52% from $54.9 million recorded in FY2023.
  • Over the past 5 years, Janux Therapeutics' Research & Development peaked at $68.4 million during FY2024, and registered a low of $3.0 million during FY2020.
  • For the 3-year period, Janux Therapeutics' Research & Development averaged around $58.9 million, with its median value being $54.9 million (2023).
  • Data for Janux Therapeutics' Research & Development shows a peak YoY skyrocketed of 762.78% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Janux Therapeutics' Research & Development stood at $3.0 million in 2020, then soared by 762.78% to $26.2 million in 2021, then surged by 103.69% to $53.4 million in 2022, then grew by 2.77% to $54.9 million in 2023, then climbed by 24.52% to $68.4 million in 2024.